Company intelligence / Profile preview

Union Biometrica

Hopkinton, Massachusetts, United Statesunionbio.com ↗

Ownership: Private
Development stage: Commercial

Overview

Union Biometrica is a pioneer in high-throughput systems for analyzing and sorting large or fragile biological samples. Their instruments are widely used in genetic screening, functional genomics, target validation, compound screening, and in vivo toxicology studies. The technology enables gentle handling of specimens such as C. elegans, zebrafish embryos/larvae, organoids, cell clusters, seeds, pollen grains, and more—objects too large or delicate for traditional flow cytometers—thus accelerating research workflows across academia and industry.

Modalities: Device (specifically, flow cytometry instrumentation)
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Union Biometrica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Union Biometrica.

Explore the full profile